Spdr S&P Biotech Etf

Moderna gave investors a scare as its stock plunged on Thursday. But it’s still one of the hottest…

AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics‘ lead drug could help power next-generation cancer…

Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

A young female worker in protective gear carefully carries a container filled with blister-packaged capsules, a crucial step…

Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…

Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images Novartis‘ failure in a…

Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…

Treasury Secretary Scott Bessent speaking to CNBC on May 14th, 2026 from Beijing, China. CNBC Hello, this is…

Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…

Biotech stocks rally on drug innovation and M&A